Cargando…
PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428788/ http://dx.doi.org/10.1097/01.HS9.0000977176.66781.66 |
_version_ | 1785090553775390720 |
---|---|
author | Kolodny, Scott Vredenburg, Michael Zhang, Jessica Jamieson, Brian |
author_facet | Kolodny, Scott Vredenburg, Michael Zhang, Jessica Jamieson, Brian |
author_sort | Kolodny, Scott |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-10428788 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Lippincott Williams & Wilkins |
record_format | MEDLINE/PubMed |
spelling | pubmed-104287882023-08-17 PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM Kolodny, Scott Vredenburg, Michael Zhang, Jessica Jamieson, Brian Hemasphere Publication Only Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428788/ http://dx.doi.org/10.1097/01.HS9.0000977176.66781.66 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
spellingShingle | Publication Only Kolodny, Scott Vredenburg, Michael Zhang, Jessica Jamieson, Brian PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM |
title | PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM |
title_full | PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM |
title_fullStr | PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM |
title_full_unstemmed | PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM |
title_short | PB2622: A PROSPECTIVE, OPEN-LABEL ONGOING STUDY OF SAFETY AND TREATMENT SATISFACTION IN ADULT IMMUNE THROMBOCYTOPENIA (ITP) SUBJECTS AFTER SWITCHING TO AVATROMBOPAG FROM ELTROMBOPAG OR ROMIPLOSTIM |
title_sort | pb2622: a prospective, open-label ongoing study of safety and treatment satisfaction in adult immune thrombocytopenia (itp) subjects after switching to avatrombopag from eltrombopag or romiplostim |
topic | Publication Only |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428788/ http://dx.doi.org/10.1097/01.HS9.0000977176.66781.66 |
work_keys_str_mv | AT kolodnyscott pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim AT vredenburgmichael pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim AT zhangjessica pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim AT jamiesonbrian pb2622aprospectiveopenlabelongoingstudyofsafetyandtreatmentsatisfactioninadultimmunethrombocytopeniaitpsubjectsafterswitchingtoavatrombopagfromeltrombopagorromiplostim |